Obesity, a global epidemic, has no effective treatment. It takes several years to develop and assess drugs targeted to melanocortin-4-receptor in the brain, a key regulator of obesity. The distinct calcium response between obesity-causing/protecting melanocortin-4-receptor variants serve as a rapid screen to narrow down drug of interest for further investigation.
This poster was uploaded for the SGS Research Showcase 2021.
Choose your favourite poster to win the People's Choice Award at the 2021 SGS Research Showcase: https://auckland.au1.qualtrics.com/jfe/form/SV_9Fw8Omf43pstYUu